Lantheus Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Frequently asked questions
To buy Lantheus Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lantheus Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lantheus Holdings Inc. is LNTH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lantheus Holdings Inc. has its primary listing on NASDAQ. You can trade Lantheus Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lantheus Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lantheus Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lantheus Holdings Inc..